Macrogenics Inc (MGNX) 35.36 $MGNX MacroGenics (MGNX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Macrogenics Inc (MGNX) 35.36 $MGNX

MacroGenics (MGNX) Downgraded From Hold to Sell
at The Street - Thu Mar 05, 11:40AM CST
MacroGenics (MGNX) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
MGNX: 35.36 (-0.22)

MacroGenics' (MGNX) CEO Scott Koenig on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 03, 8:18PM CST

MGNX: 35.36 (-0.22)

MacroGenics misses by $0.33, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 3:11PM CST

MGNX: 35.36 (-0.22)

MacroGenics (MGNX) Catches Eye: Stock Gains 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 8:11AM CST
MacroGenics, Inc. (MGNX) was a big mover last session, as the company saw its shares rise over 7% on the day.
MGNX: 35.36 (-0.22), PAHC: 35.01 (+0.10)

Zimmer (ZMH) Q4 Earnings Beat, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:13AM CST
Zimmer Holdings (ZMH) reported fourth-quarter 2014 adjusted earnings per share (EPS) of $1.71, up 3% year over year.
MGNX: 35.36 (-0.22), ZMH: 116.35 (-2.83), CSII: 36.10 (-1.36), OSUR: 7.17 (+0.06)

Dengue Therapeutic Pipeline Drugs and Companies Review H1 2015 Report at RnRMarketResearch.com
PRWeb - Fri Jan 23, 7:45PM CST
The report "Dengue - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Dengue. Dengue is a disease caused by bite of the mosquito (Aedes Mosquito) which is infected with a dengue virus. The disease can affect a person through fever, headache, muscle and joint pain. The disease if not cured on time may result into fatal occurrences like dengue hemorrhagic fever. The disease may also result in failure of the circulatory systems of the body. Dengue is found in the Asian Subcontinent. These are primarily the regions wherein the population is crowded & there is scope for the mosquitoes to quantify. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Complete Report is Available @ http://www.rnrmarketresearch.com/dengue-pipel...eport.html .
MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41), UTHR: 160.65 (-0.71), MRK: 56.84 (-1.14), NNVC: 2.72 (-0.10), GSK: 46.73 (-0.87), SIGA: 2.40 (+0.04)

Medtronic Starts Cyro-FIRST Trial for AF Patients, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 1:40PM CST
Management at Medtronic (MDT) expects the AF patient population to expand exponentially over the next generation. Consequently, the cryoballoon ablation therapy should be able to garner high demand.
MGNX: 35.36 (-0.22), ICUI: 86.15 (-2.85), MDT: 76.48 (-2.02), CNAT: 6.05 (-0.54)

Surging Earnings Estimates Signal Good News for MacroGenics (MGNX) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 7:42AM CST
The positive earnings estimate revisions suggest that analysts are becoming more optimistic on MacroGenics' (MGNX) earnings for the coming quarter and year
MGNX: 35.36 (-0.22)

Will MacroGenics (MGNX) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 7:02AM CST
Will MacroGenics (MGNX) Continue to Surge Higher?
MGNX: 35.36 (-0.22)

Commit To Buy MacroGenics At $30, Earn 23.9% Annualized Using Options
at The Street - Tue Dec 30, 12:56PM CST
Investors eyeing a purchase of MacroGenics, Inc stock, but tentative about paying the going market price of $33.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
MGNX: 35.36 (-0.22)

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Dec 26, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. What should the Seeking Alpha community be reading and writing about? Please leave...
MGNX: 35.36 (-0.22), CYTK: 7.80 (-0.11), JNJ: 100.11 (-2.41), ESRX: 82.27 (-2.01), ALNY: 107.67 (-3.89), GILD: 101.81 (-1.61), ACHN: 11.39 (+0.40), ABBV: 55.64 (-1.22), BMY: 65.12 (-0.93), ANIK: 39.63 (-0.33)

3D Systems Climbs Despite Setback
at The Street - Fri Dec 26, 1:00PM CST
Gulf Coast Ultra Deep Royalty Trust (NASDAQ:GULTU), MacroGenics Inc (NASDAQ:MGNX) and 3D Systems Corporation (NYSE DD) are making notable gains this Friday. Posting losses today are Bio Blast Pharm...
MGNX: 35.36 (-0.22), DDD: 28.50 (-0.51), TAS: 0.54 (-0.03), ORPN: 7.03 (-0.35), GULTU: 0.96 (unch)

MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 2:00PM CST
MacroGenics, Inc. (MGNX) entered into a collaboration and license agreement with Johnson & Johnson for the development and commercialization of MGD011.
MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41), MDCO: 28.78 (-0.86), BMY: 65.12 (-0.93), FPRX: 24.55 (-1.09)

MacroGenics investors take some money off the table
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 9:12AM CST

MGNX: 35.36 (-0.22)

Equities Lead Investor Sentiments: Coverage Initiated on AMETEK, FedEx, MacroGenics, Walgreens and Apple
PR Newswire - Tue Dec 23, 8:00AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including AMETEK (NYSE: AME), FedEx (NYSE: FDX), MacroGenics (NASDAQ: MGNX), Walgreens (NYSE: WAG), and Apple (NASDAQ: AAPL). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MGNX: 35.36 (-0.22), FDX: 173.19 (-1.63), AME: 52.02 (-0.90), AAPL: 126.60 (+0.19), WAG: 76.05 (-0.49)

MacroGenics, J&J make deal
at Investor's Business Daily - Mon Dec 22, 5:30PM CST
Biotech MacroGenics (MGNX) inked a licensing deal worth as much as $700 mil with Janssen Biotech, a Johnson & Johnson (JNJ) unit, which agreed to pay $50 mil upfront for rights to MGD011, an antibody that targets 2 biomarkers associated with...
MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41)

MacroGenics Partners With J&J; Stock Jumps
at Investor's Business Daily - Mon Dec 22, 11:33AM CST
Biotech MacroGenics (MGNX) cut a licensing deal worth as much as $700 million with Johnson & Johnson's drug-development arm Monday, sending its stock up 11% to a 10-month high above 38 on the stock market today. Johnson & Johnson's (JNJ) unit Janssen...
MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41)

MacroGenics teams up with Janssen in blood cancer
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:08AM CST

MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41)

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
GlobeNewswire - Mon Dec 22, 5:00AM CST
-- MacroGenics licenses MGD011 (CD19 x CD3 DART(R)) to Janssen
MGNX: 35.36 (-0.22), JNJ: 100.11 (-2.41)

Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:50PM CST
On Dec 16, 2014, Zacks Investment Research upgraded Boston Scientific Corporation (BSX) to a Zacks Rank #2 (Buy).
MGNX: 35.36 (-0.22), BSX: 16.56 (-0.41), ABAX: 62.39 (+0.24), HSP: 87.90 (+0.05)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 81

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 107

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 86

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 95

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 98

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 39

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 136

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 29

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 85

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading

Top 5 Most Recently Viewed Articles

Cascade Milling Enhances Operations with New Facility Expansion

Updated Category News Views 988

Expansion Plans at Cascade Milling Cascade Milling is thrilled to announce the expansion of its organic flour milling facility. This extensive enhancement involves adding a new building dedicated to boosting production. With organic products becoming increasingly popular, this expansion will help the company meet the growing demands for quality organic flours, grains, and...

Continue Reading
Dollar Tree's Stock Trends: What Investors Should Know Now

Updated Category News Views 158

Dollar Tree Inc. Stock Shows Promising Growth Dollar Tree Inc. (NASDAQ: DLTR) shares are experiencing upward movement recently, indicating a possible emerging trend. Notably, the stock seems to be gaining momentum. Market Dynamics and Recent Developments After being deemed oversold, Dollar Tree's stock has gained interest, particularly following recent earnings reports...

Continue Reading
Important Update for Workhorse Group Shareholders About Call

Updated Category News Views 141

Engaging Shareholders Ahead of Upcoming Conference Call In a crucial step to engage with shareholders, Workhorse Group Inc. (Nasdaq: WKHS) is gearing up for a conference call designed to address significant updates. This call is an opportunity for shareholders to discuss the company's important financial results and recently announced transactions. Call Details for...

Continue Reading
LeafLink's Strategic Acquisition of Leaf Trade to Boost Growth

Updated Category News Views 222

LeafLink Expands Horizons with Leaf Trade Acquisition LeafLink, a prominent name in the cannabis wholesale industry, has recently made headlines with its acquisition of Leaf Trade. This strategic move is set to create a significant impact on the market by streamlining operations and addressing the growing needs of multi-state operators (MSOs) and enterprise-level cannabis...

Continue Reading
Florida's First Behavioral Health Teaching Hospital Unveiled

Updated Category News Views 189

Welcoming Florida's First Behavioral Health Teaching Hospital The TGH Behavioral Health Hospital represents a significant milestone in mental health treatment. This facility offers specialized and personalized care for various behavioral and mental health conditions. Inauguration Ceremony at TGH Recently, leaders from Tampa General Hospital (TGH), Lifepoint Health, and...

Continue Reading